NASDAQ | ETF
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market.
Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 8.04% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 7.49% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 6.41% |
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 5.56% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 4.68% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.54% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.29% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 3.34% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 3.29% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 3.02% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 2.76% |
| 0QIU | Novo Nordisk A/S Class B | 2.67% | ||
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 2.65% |
| ARGX | Argen-X | Healthcare | Biotechnology | 2.48% |
| ROP | Roche Holding AG | Healthcare | Drug Manufacturers - General | 2.33% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 2.20% |
| UCB | UCB SA | Healthcare | Biotechnology | 2.14% |
| GSK | GSK plc | Healthcare | Drug Manufacturers - General | 1.98% |
| 7741 | Hoya Cor | Healthcare | Medical Instruments & Supplies | 1.94% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 1.87% |